| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.866 | 0.001 | 0.866 | Leukotriene B4 receptor 1 antagonist | 0.851 0.001 CID_154699637 0.624 0.002 CID_154699593 | ||
| 0.807 | 0.001 | 0.807 | Leukotriene B4 receptor 2 antagonist | 0.757 0.001 CID_154699637 0.6 0.001 CID_154699593 | ||
| 0.729 | 0.011 | 0.729 | Cyclophilin D inhibitor | 0.715 0.013 CID_154699637 0.636 0.022 CID_154699593 | ||
| 0.524 | 0.029 | 0.627 | Cholesterol antagonist | 0.567 0.023 CID_154699637 0.627 0.015 CID_154699593 | CID_154699593 | |
| 0.41 | 0.002 | 0.53 | Leukotriene B4 antagonist | 0.53 0.002 CID_154699637 0.268 0.003 CID_154699593 | CID_154699637 | |
| 0.415 | 0.034 | 0.544 | Lipoxygenase inhibitor | 0.544 0.014 CID_154699637 0.432 0.03 CID_154699593 | CID_154699637 | |
| 0.44 | 0.06 | 0.477 | Antibacterial | 0.477 0.047 CID_154699637 0.449 0.057 CID_154699593 | CID_154699637 | |
| 0.418 | 0.067 | 0.418 | 5 Hydroxytryptamine release inhibitor | 0.383 0.089 CID_154699637 0.379 0.092 CID_154699593 | ||
| 0.393 | 0.086 | 0.393 | Calcium channel L-type activator | 0.335 0.129 CID_154699637 0.262 0.193 CID_154699593 | ||
| 0.427 | 0.123 | 0.552 | Antiinflammatory | 0.513 0.082 CID_154699637 0.552 0.068 CID_154699593 | CID_154699593 | |
| 0.302 | 0.004 | 0.386 | Leukotriene antagonist | 0.386 0.003 CID_154699637 0.204 0.005 CID_154699593 | CID_154699637 | |
| 0.402 | 0.11 | 0.402 | Caspase 9 stimulant | 0.338 0.155 CID_154699637 0.274 0.224 CID_154699593 | ||
| 0.302 | 0.017 | 0.314 | Neurotrophic factor enhancer | 0.314 0.015 CID_154699637 0.261 0.033 CID_154699593 | CID_154699637 | |
| 0.327 | 0.056 | 0.364 | Sodium/bile acid cotransporter inhibitor | 0.364 0.032 CID_154699637 0.298 0.081 CID_154699593 | CID_154699637 | |
| 0.298 | 0.049 | 0.374 | Hypolipemic | 0.282 0.055 CID_154699637 0.374 0.03 CID_154699593 | CID_154699593 | |
| 0.337 | 0.106 | 0.439 | Histamine release inhibitor | 0.305 0.121 CID_154699637 0.439 0.055 CID_154699593 | CID_154699593 | |
| 0.234 | 0.005 | 0.234 | NMDA 2B receptor antagonist | 0.196 0.006 CID_154699637 0.097 0.016 CID_154699593 | ||
| 0.215 | 0.005 | 0.215 | Leukotriene synthesis inhibitor | 0.209 0.005 CID_154699637 0.181 0.006 CID_154699593 | ||
| 0.304 | 0.095 | 0.304 | Vasodilator, peripheral | 0.215 0.159 CID_154699637 0.243 0.132 CID_154699593 | ||
| 0.264 | 0.069 | 0.273 | Hypoglycemic | 0.273 0.064 CID_154699637 0.186 0.127 CID_154699593 | CID_154699637 | |
| 0.285 | 0.103 | 0.411 | Transcription factor NF kappa B inhibitor | 0.363 0.073 CID_154699637 0.411 0.061 CID_154699593 | CID_154699593 | |
| 0.187 | 0.013 | 0.224 | AMP-activated protein kinase stimulant | 0.224 0.008 CID_154699637 0.144 0.032 CID_154699593 | CID_154699637 | |
| 0.224 | 0.052 | 0.224 | Insulin sensitizer | 0.192 0.081 CID_154699637 | ||
| 0.215 | 0.044 | 0.215 | 3C-like protease (Human coronavirus) inhibitor | 0.15 0.101 CID_154699637 0.148 0.104 CID_154699593 | ||
| 0.305 | 0.137 | 0.368 | Analgesic | 0.308 0.136 CID_154699637 0.368 0.099 CID_154699593 | CID_154699593 | |
| 0.284 | 0.126 | 0.293 | Immunosuppressant | 0.252 0.146 CID_154699637 0.293 0.119 CID_154699593 | CID_154699593 | |
| 0.196 | 0.043 | 0.196 | Protein kinase stimulant | 0.164 0.059 CID_154699637 0.128 0.085 CID_154699593 | ||
| 0.274 | 0.127 | 0.3 | Toll-Like receptor 7 agonist | 0.3 0.11 CID_154699637 | CID_154699637 | |
| 0.205 | 0.062 | 0.212 | Hepatoprotectant | 0.212 0.058 CID_154699637 0.208 0.06 CID_154699593 | CID_154699637 | |
| 0.186 | 0.051 | 0.186 | ATPase inhibitor | 0.165 0.077 CID_154699637 0.183 0.054 CID_154699593 | ||
| 0.229 | 0.096 | 0.302 | Antioxidant | 0.302 0.061 CID_154699637 0.237 0.091 CID_154699593 | CID_154699637 | |
| 0.2 | 0.067 | 0.224 | Nitric oxide antagonist | 0.224 0.059 CID_154699637 0.211 0.063 CID_154699593 | CID_154699637 | |
| 0.265 | 0.135 | 0.289 | Toll-Like receptor agonist | 0.289 0.118 CID_154699637 | CID_154699637 | |
| 0.153 | 0.036 | 0.153 | Ca2+-transporting ATPase inhibitor | 0.146 0.052 CID_154699637 0.153 0.037 CID_154699593 | ||
| 0.161 | 0.044 | 0.161 | Glutamate receptor antagonist | 0.117 0.078 CID_154699637 | ||
| 0.167 | 0.059 | 0.167 | Insulin secretagoues | 0.117 0.116 CID_154699637 | ||
| 0.163 | 0.063 | 0.184 | Phospholipase A2 inhibitor | 0.184 0.052 CID_154699637 0.126 0.107 CID_154699593 | CID_154699637 | |
| 0.129 | 0.031 | 0.129 | NMDA receptor antagonist | 0.099 0.048 CID_154699637 | ||
| 0.119 | 0.024 | 0.119 | NMDA 2 receptor antagonist | 0.108 0.028 CID_154699637 | ||
| 0.12 | 0.026 | 0.159 | Ornithine decarboxylase inhibitor | 0.119 0.027 CID_154699637 0.159 0.009 CID_154699593 | CID_154699593 | |
| 0.126 | 0.035 | 0.171 | Uric acid excretion stimulant | 0.13 0.032 CID_154699637 0.171 0.018 CID_154699593 | CID_154699593 | |
| 0.101 | 0.012 | 0.101 | Peroxisome proliferator-activated receptor alpha agonist | 0.079 0.018 CID_154699637 0.07 0.022 CID_154699593 | ||
| 0.12 | 0.031 | 0.12 | ABCA1 expression enhancer | 0.099 0.052 CID_154699637 0.097 0.054 CID_154699593 | ||
| 0.152 | 0.068 | 0.152 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.148 0.075 CID_154699637 0.146 0.081 CID_154699593 | ||
| 0.093 | 0.013 | 0.093 | Thromboxane antagonist | 0.09 0.015 CID_154699637 0.069 0.027 CID_154699593 | ||
| 0.188 | 0.111 | 0.188 | Platelet antagonist | 0.154 0.14 CID_154699637 0.188 0.11 CID_154699593 | ||
| 0.087 | 0.012 | 0.087 | Thromboxane A2 antagonist | 0.079 0.015 CID_154699637 0.068 0.022 CID_154699593 | ||
| 0.094 | 0.019 | 0.094 | Peroxisome proliferator-activated receptor gamma antagonist | 0.094 0.019 CID_154699637 0.066 0.065 CID_154699593 | ||
| 0.098 | 0.029 | 0.098 | Peroxisome proliferator-activated receptor gamma agonist | 0.097 0.029 CID_154699637 0.082 0.039 CID_154699593 | ||
| 0.152 | 0.086 | 0.17 | Arachidonic acid antagonist | 0.156 0.081 CID_154699637 0.17 0.065 CID_154699593 | CID_154699593 | |
| 0.158 | 0.094 | 0.158 | Lipocortins synthesis antagonist | 0.138 0.125 CID_154699637 0.153 0.1 CID_154699593 | ||
| 0.071 | 0.01 | 0.071 | Factor III inhibitor | 0.068 0.012 CID_154699637 0.069 0.011 CID_154699593 | ||
| 0.114 | 0.054 | 0.203 | 5-Lipoxygenase inhibitor | 0.203 0.024 CID_154699637 0.15 0.038 CID_154699593 | CID_154699637 | |
| 0.218 | 0.158 | 0.255 | Apoptosis antagonist | 0.255 0.122 CID_154699637 0.224 0.153 CID_154699593 | CID_154699637 | |
| 0.192 | 0.135 | 0.216 | DNA synthesis inhibitor | 0.216 0.1 CID_154699593 | CID_154699593 | |
| 0.064 | 0.008 | 0.111 | Leukotriene D4 antagonist | 0.111 0.005 CID_154699637 0.024 0.02 CID_154699593 | CID_154699637 | |
| 0.174 | 0.12 | 0.233 | Antiamyloidogenic | 0.23 0.081 CID_154699637 0.233 0.079 CID_154699593 | CID_154699593 | |
| 0.064 | 0.012 | 0.064 | Retinoid X receptor agonist | 0.045 0.02 CID_154699637 0.035 0.025 CID_154699593 | ||
| 0.084 | 0.032 | 0.14 | Potassium channel large-conductance Ca-activated activator | 0.14 0.012 CID_154699637 0.089 0.03 CID_154699593 | CID_154699637 | |
| 0.13 | 0.081 | 0.13 | Neurotrophic factor | 0.119 0.097 CID_154699637 0.126 0.086 CID_154699593 | ||
| 0.215 | 0.169 | 0.299 | Vasodilator, coronary | 0.213 0.17 CID_154699637 0.299 0.088 CID_154699593 | CID_154699593 | |
| 0.138 | 0.092 | 0.173 | Protein-tyrosine phosphatase inhibitor | 0.173 0.061 CID_154699637 0.125 0.108 CID_154699593 | CID_154699637 | |
| 0.182 | 0.137 | 0.411 | Cardiotonic | 0.411 0.027 CID_154699593 | CID_154699593 | |
| 0.052 | 0.008 | 0.052 | Prostaglandin EP4 antagonist | 0.025 0.019 CID_154699637 0.029 0.016 CID_154699593 | ||
| 0.051 | 0.007 | 0.067 | Cholesterol ester transfer protein antagonist | 0.038 0.015 CID_154699637 0.067 0.004 CID_154699593 | CID_154699593 | |
| 0.102 | 0.058 | 0.126 | Xanthine oxidase inhibitor | 0.126 0.044 CID_154699637 0.093 0.067 CID_154699593 | CID_154699637 | |
| 0.113 | 0.069 | 0.113 | Microtubule formation inhibitor | |||
| 0.047 | 0.004 | 0.047 | Prostaglandin H2 antagonist | 0.042 0.005 CID_154699637 0.04 0.005 CID_154699593 | ||
| 0.205 | 0.162 | 0.215 | Caspase 3 stimulant | 0.215 0.148 CID_154699637 | CID_154699637 | |
| 0.12 | 0.078 | 0.126 | Alpha-N-acetylglucosaminidase inhibitor | 0.126 0.072 CID_154699593 | CID_154699593 | |
| 0.114 | 0.073 | 0.114 | Adenylate cyclase inhibitor | |||
| 0.132 | 0.092 | 0.132 | Hemostatic | |||
| 0.138 | 0.1 | 0.16 | Melanin inhibitor | 0.16 0.069 CID_154699637 0.132 0.111 CID_154699593 | CID_154699637 | |
| 0.051 | 0.014 | 0.061 | Farnesoid X receptor agonist | 0.04 0.024 CID_154699637 0.061 0.01 CID_154699593 | CID_154699593 | |
| 0.046 | 0.011 | 0.046 | Free fatty acid receptor 1 antagonist | 0.031 0.028 CID_154699637 0.031 0.028 CID_154699593 | ||
| 0.095 | 0.06 | 0.167 | Potassium channel (Ca-activated) activator | 0.167 0.023 CID_154699637 0.102 0.054 CID_154699593 | CID_154699637 | |
| 0.049 | 0.015 | 0.049 | Retinoic acid alpha receptor agonist | 0.049 0.015 CID_154699637 0.049 0.015 CID_154699593 | ||
| 0.052 | 0.018 | 0.052 | GABA B receptor antagonist | |||
| 0.135 | 0.101 | 0.135 | Interferon gamma antagonist | 0.132 0.108 CID_154699637 | ||
| 0.047 | 0.016 | 0.047 | Retinoid X alpha receptor agonist | 0.033 0.027 CID_154699637 0.032 0.027 CID_154699593 | ||
| 0.039 | 0.009 | 0.069 | Prostaglandin EP2 agonist | 0.069 0.004 CID_154699593 | CID_154699593 | |
| 0.066 | 0.037 | 0.066 | Prostaglandin F2 alpha antagonist | 0.064 0.039 CID_154699637 0.057 0.052 CID_154699593 | ||
| 0.042 | 0.013 | 0.125 | Prostaglandin agonist | 0.032 0.02 CID_154699637 0.125 0.004 CID_154699593 | CID_154699593 | |
| 0.036 | 0.008 | 0.038 | Sodium/glucose cotransporter inhibitor | 0.038 0.007 CID_154699637 | CID_154699637 | |
| 0.065 | 0.037 | 0.067 | Prostaglandin EP2 antagonist | 0.067 0.035 CID_154699637 | CID_154699637 | |
| 0.057 | 0.03 | 0.095 | Prostaglandin E2 antagonist | 0.095 0.015 CID_154699637 | CID_154699637 | |
| 0.059 | 0.033 | 0.073 | Prostaglandin antagonist | 0.073 0.025 CID_154699637 | CID_154699637 | |
| 0.097 | 0.071 | 0.108 | Carbonic anhydrase XV inhibitor | 0.108 0.057 CID_154699637 0.1 0.067 CID_154699593 | CID_154699637 | |
| 0.146 | 0.12 | 0.159 | Non-steroidal antiinflammatory agent | 0.159 0.105 CID_154699637 | CID_154699637 | |
| 0.102 | 0.076 | 0.134 | Protein-tyrosine phosphatase 1B inhibitor | 0.134 0.053 CID_154699637 0.092 0.087 CID_154699593 | CID_154699637 | |
| 0.035 | 0.01 | 0.037 | Sodium/glucose cotransporter 2 inhibitor | 0.037 0.009 CID_154699637 | CID_154699637 | |
| 0.057 | 0.033 | 0.057 | Thromboxane synthase inhibitor | 0.05 0.049 CID_154699637 0.057 0.033 CID_154699593 | ||
| 0.044 | 0.02 | 0.072 | Glutamate (mGluR group II) antagonist | 0.072 0.008 CID_154699593 | CID_154699593 | |
| 0.029 | 0.006 | 0.029 | Free fatty acid receptor 1 agonist | 0.023 0.009 CID_154699637 0.023 0.009 CID_154699593 | ||
| 0.083 | 0.061 | 0.083 | 3C-Like protease (SARS coronavirus) inhibitor | 0.08 0.07 CID_154699637 | ||
| 0.036 | 0.014 | 0.036 | Purinergic P2Y14 antagonist | 0.031 0.019 CID_154699637 0.036 0.014 CID_154699593 | ||
| 0.031 | 0.01 | 0.101 | Prostaglandin E2 agonist | 0.022 0.018 CID_154699637 0.101 0.004 CID_154699593 | CID_154699593 | |
| 0.064 | 0.043 | 0.085 | Kallikrein 7 inhibitor | 0.085 0.01 CID_154699637 | CID_154699637 | |
| 0.157 | 0.137 | 0.226 | Free radical scavenger | 0.226 0.08 CID_154699637 0.156 0.138 CID_154699593 | CID_154699637 | |
| 0.105 | 0.086 | 0.131 | Estrogen antagonist | 0.124 0.048 CID_154699637 0.131 0.037 CID_154699593 | CID_154699593 | |
| 0.052 | 0.033 | 0.086 | Diacylglycerol O-acyltransferase inhibitor | 0.086 0.012 CID_154699593 | CID_154699593 | |
| 0.041 | 0.023 | 0.041 | TRPM8 blocker | 0.035 0.031 CID_154699637 | ||
| 0.085 | 0.068 | 0.085 | Triose-phosphate isomerase inhibitor | |||
| 0.039 | 0.022 | 0.041 | Glutamate (mGluR3) antagonist | 0.033 0.032 CID_154699637 0.041 0.019 CID_154699593 | CID_154699593 | |
| 0.154 | 0.139 | 0.169 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.169 0.11 CID_154699637 0.158 0.131 CID_154699593 | CID_154699637 | |
| 0.099 | 0.084 | 0.112 | Electron transport complex I inhibitor | 0.112 0.06 CID_154699637 | CID_154699637 | |
| 0.058 | 0.043 | 0.064 | Androgen agonist | 0.064 0.036 CID_154699593 | CID_154699593 | |
| 0.038 | 0.025 | 0.038 | Delayed rectifier potassium channel blocker | |||
| 0.158 | 0.146 | 0.158 | Vasodilator | |||
| 0.084 | 0.073 | 0.114 | HIV-1 integrase (Overall Integration) inhibitor | 0.114 0.043 CID_154699637 | CID_154699637 | |
| 0.113 | 0.103 | 0.131 | Papain-like protease (SARS coronavirus) inhibitor | 0.131 0.058 CID_154699637 0.111 0.107 CID_154699593 | CID_154699637 | |
| 0.035 | 0.026 | 0.035 | Glutamate (mGluR8) antagonist | 0.034 0.029 CID_154699637 0.035 0.027 CID_154699593 | ||
| 0.029 | 0.021 | 0.05 | Glutamate (mGluR2) antagonist | 0.05 0.008 CID_154699593 | CID_154699593 | |
| 0.018 | 0.009 | 0.018 | Prostaglandin EP4 agonist | |||
| 0.139 | 0.132 | 0.139 | Phospholipase C inhibitor | |||
| 0.121 | 0.114 | 0.121 | Sigma receptor agonist | |||
| 0.038 | 0.032 | 0.038 | Neurokinin 1 antagonist | |||
| 0.041 | 0.036 | 0.041 | Dihydroorotase inhibitor | |||
| 0.041 | 0.036 | 0.041 | Sphingosine 1-phosphate receptor agonist | |||
| 0.038 | 0.035 | 0.038 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.057 | 0.054 | 0.057 | Heme oxygenase stimulant | 0.057 0.056 CID_154699637 0.057 0.055 CID_154699593 | ||
| 0.018 | 0.017 | 0.018 | Retinoic acid alpha receptor antagonist | 0.018 0.017 CID_154699637 | ||
| 0.018 | 0.017 | 0.028 | Progesterone receptor B antagonist | 0.028 0.005 CID_154699637 | CID_154699637 | |
| 0.044 | 0.044 | 0.047 | Dihydroorotate dehydrogenase inhibitor | 0.047 0.04 CID_154699637 | CID_154699637 | |
| 0.03 | 0.035 | 0.042 | 5-Alpha-reductase inhibitor | 0.042 0.023 CID_154699593 | CID_154699593 | |
| 0.084 | 0.089 | 0.09 | Bile acid receptor antagonist | 0.09 0.075 CID_154699637 | CID_154699637 | |
| 0.174 | 0.179 | 0.202 | Transcription factor STAT inhibitor | 0.202 0.136 CID_154699593 | CID_154699593 | |
| 0.262 | 0.268 | 0.269 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.269 0.257 CID_154699593 | CID_154699593 | |
| 0.086 | 0.092 | 0.11 | Estrogen receptor beta antagonist | 0.11 0.047 CID_154699637 0.095 0.074 CID_154699593 | CID_154699637 | |
| 0.05 | 0.057 | 0.058 | Adenine nucleotide translocase inhibitor | 0.052 0.049 CID_154699637 0.058 0.033 CID_154699593 | CID_154699593 | |
| 0.026 | 0.034 | 0.035 | Peroxisome proliferator-activated receptor delta agonist | 0.035 0.021 CID_154699593 | CID_154699593 | |
| 0.043 | 0.054 | 0.061 | Xanthine dehydrogenase inhibitor | 0.061 0.037 CID_154699637 | CID_154699637 | |
| 0.012 | 0.023 | 0.022 | Prostaglandin EP1 antagonist | 0.022 0.013 CID_154699637 | CID_154699637 | |
| 0.003 | 0.015 | 0.006 | Insulin like growth factor 3 antagonist | 0.006 0.004 CID_154699593 | CID_154699593 | |
| 0.044 | 0.056 | 0.078 | Dopamine uptake inhibitor | 0.078 0.026 CID_154699593 | CID_154699593 | |
| 0.102 | 0.114 | 0.116 | Interleukin 4 antagonist | 0.116 0.091 CID_154699637 0.115 0.093 CID_154699593 | CID_154699637 | |
| 0.066 | 0.08 | 0.098 | Estrogen receptor alpha antagonist | 0.08 0.049 CID_154699637 0.098 0.028 CID_154699593 | CID_154699593 | |
| 0.064 | 0.079 | 0.098 | Macrophage migration inhibitory factor inhibitor | 0.098 0.036 CID_154699637 | CID_154699637 | |
| 0.023 | 0.04 | 0.029 | Estrogen-related receptor alpha antagonist | 0.029 0.027 CID_154699637 | CID_154699637 | |
| 0.045 | 0.063 | 0.208 | 5 Hydroxytryptamine uptake inhibitor | 0.208 0.01 CID_154699593 | CID_154699593 | |
| 0.093 | 0.112 | 0.126 | Aldehyde dehydrogenase inhibitor | 0.126 0.065 CID_154699593 | CID_154699593 | |
| 0.088 | 0.109 | 0.132 | Amylase inhibitor | 0.132 0.074 CID_154699637 | CID_154699637 | |
| 0.062 | 0.085 | 0.072 | Keratolytic | 0.072 0.061 CID_154699637 | CID_154699637 | |
| 0.024 | 0.047 | 0.04 | Glutamate (mGluR group II) agonist | 0.04 0.021 CID_154699593 | CID_154699593 | |
| 0.179 | 0.205 | 0.208 | Antithrombotic | 0.208 0.167 CID_154699593 | CID_154699593 | |
| 0.088 | 0.115 | 0.109 | Cyclooxygenase 1 inhibitor | 0.109 0.09 CID_154699637 | CID_154699637 | |
| 0.125 | 0.153 | 0.135 | Heat shock protein 70 antagonist | 0.135 0.094 CID_154699637 | CID_154699637 | |
| 0.019 | 0.048 | 0.032 | Glutamate (mGluR2) agonist | 0.032 0.023 CID_154699593 | CID_154699593 | |
| 0.165 | 0.197 | 0.238 | Hypoxia-inducible factor 1 alpha inhibitor | 0.238 0.111 CID_154699637 0.232 0.117 CID_154699593 | CID_154699637 | |
| 0.06 | 0.094 | 0.082 | Androgen antagonist | 0.082 0.063 CID_154699637 | CID_154699637 | |
| 0.036 | 0.078 | 0.052 | HIV-1 integrase (Strand Transfer) inhibitor | 0.052 0.048 CID_154699637 | CID_154699637 | |
| 0.04 | 0.086 | 0.106 | Adrenaline uptake inhibitor | 0.106 0.017 CID_154699593 | CID_154699593 | |
| 0.073 | 0.12 | 0.105 | Topoisomerase II inhibitor | 0.097 0.089 CID_154699637 0.105 0.081 CID_154699593 | CID_154699593 | |
| 0.022 | 0.069 | 0.042 | Urate transporter 1 inhibitor | 0.042 0.024 CID_154699593 | CID_154699593 | |
| 0.029 | 0.077 | 0.041 | Vanilloid 3 antagonist | 0.041 0.02 CID_154699593 | CID_154699593 | |
| 0.211 | 0.259 | 0.28 | Apoptosis agonist | 0.28 0.187 CID_154699637 0.258 0.206 CID_154699593 | CID_154699637 | |
| 0.152 | 0.207 | 0.183 | Transcription factor STAT3 inhibitor | 0.183 0.16 CID_154699593 | CID_154699593 | |
| 0.069 | 0.126 | 0.082 | T cell inhibitor | 0.082 0.057 CID_154699593 | CID_154699593 | |
| 0.07 | 0.127 | 0.102 | Cystathionine beta-synthase inhibitor | 0.102 0.074 CID_154699637 | CID_154699637 | |
| 0.027 | 0.084 | 0.121 | Dopamine transporter inhibitor | 0.121 0.008 CID_154699593 | CID_154699593 | |
| 0.033 | 0.093 | 0.095 | Factor IXa inhibitor | 0.095 0.011 CID_154699593 | CID_154699593 | |
| 0.081 | 0.148 | 0.125 | Lipid peroxidase inhibitor | 0.11 0.105 CID_154699637 0.125 0.088 CID_154699593 | CID_154699593 | |
| 0.058 | 0.128 | 0.098 | Potassium channel activator | 0.098 0.05 CID_154699593 | CID_154699593 | |
| 0.039 | 0.115 | 0.073 | Glutamate receptor agonist | 0.073 0.06 CID_154699593 | CID_154699593 | |
| 0.012 | 0.088 | 0.036 | Glucocorticoid antagonist | 0.036 0.021 CID_154699593 | CID_154699593 | |
| 0.17 | 0.247 | 0.224 | Antiobesity | 0.224 0.182 CID_154699593 | CID_154699593 | |
| 0.049 | 0.131 | 0.107 | Monophenol monooxygenase inhibitor | 0.107 0.071 CID_154699637 | CID_154699637 | |
| 0.039 | 0.128 | 0.061 | Ca(v)3.2 blocker | 0.061 0.037 CID_154699593 | CID_154699593 | |
| 0.108 | 0.203 | 0.152 | MAP kinase kinase 4 inhibitor | 0.152 0.057 CID_154699593 | CID_154699593 | |
| 0.024 | 0.176 | 0.047 | Potassium channel (ATP-sensitive) activator | 0.047 0.036 CID_154699593 | CID_154699593 | |
| 0.026 | 0.18 | 0.049 | Potassium channel (Inward rectifier) activator | 0.049 0.038 CID_154699593 | CID_154699593 | |
| 0.014 | 0.244 | 0.062 | Maillard reaction inhibitor | 0.062 0.033 CID_154699593 | CID_154699593 | |
| 0.061 | 0.32 | 0.213 | Spasmolytic | 0.213 0.109 CID_154699593 | CID_154699593 | |
| 0.006 | 0.267 | 0.034 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.034 0.025 CID_154699593 | CID_154699593 | |
| 0.072 | 0.751 | 0.219 | MAP kinase kinase 3 inhibitor | 0.219 0.076 CID_154699593 | CID_154699593 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |